<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=896170837107954&amp;ev=PageView&amp;noscript=1">
  • Español
      • BPH Symptom Score

        UroLift ATC® Advanced Tissue Control System

        Now it's easier to treat a broad spectrum of BPH patients

        The new UroLift ATC® Advanced Tissue Control System delivers the same, proven implant through an enhanced delivery device tip that enables urologists to more easily treat BPH patients with challenging anatomies, including an obstructive median lobe and large lateral lobes. The wings are designed to provide more tissue control which may reduce procedural manipulations.  

        1 Tissue Control Wings

        • Hold tissue during manipulation for enhanced control
        • Shaped to minimize view obstruction

        2 Needle Location Marker

        • Laser-etched markings for targeting accuracy and predictable implant placement
        • Needle penetrates tissue in line with the markings

        3 Atraumatic Design

        • Tissue control wings have rounded edges
        • Wings are constructed of flexible stainless steel material

        ATC image with markers-1

         

        "My experience with the UroLift ATC System has been overwhelmingly positive. The new design features of the UroLift ATC System make it easier for me to treat patients with complex anatomies, and especially increase my confidence in treating patients with an obstructive median lobe."

        Steven Gange, M.D., Salt Lake City, Utah+

         

        Cystoscopic View

        Illustrated Cystoscopic View

        Wings hold tissue, providing enhanced control during the procedure

        Treat the Median Lobe With Confidence        

        Pre-Procedure image-1

        Post-Procedure image-2
        Clinical Results*

        *The Clinical Results page features studies based on the previous generation UroLift System (UL400)

        Indicated for the treatment of symptoms of an enlarged prostate up to 100cc in men 45 years or older. As with any medical procedure, individual results may vary. Most common side effects are temporary and can include discomfort when urinating, urgency, inability to control the urge, pelvic pain, and some blood in the urine.1 Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention. Learn More

        Consult the Instructions for Use (IFU) for more information.

        Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.

        Source Information

        + Dr. Steven Gange is a paid consultant for NeoTract | Teleflex Interventional Urology

        1. Roehrborn, J Urol 2013

        4155 Hopyard Road

        Pleasanton, CA 94588

        Phone: (925) 401-0700

        Fax: (925) 401-0699

        © 2023 Teleflex Incorporated. All rights reserved. MAC02126-02 Rev A    |    Terms of Use   |    Privacy Policy   |   Patient Safety

        MA00914-01 Rev B